Nello Mainolfi | Founder and Chief Executive Officer |
Jared Gollob | Chief Medical Officer |
Bruce Jacobs | Chief Financial Officer |
Eliana Merle | UBS |
Brad Canino | Stifel |
Paul Jeng | Guggenheim |
Gospel Enyindah-Asonye | Morgan Stanley |
Kalpit Patel | B. Riley |
Divya Rao | Cowen and Company |
Eric Joseph | JPMorgan |
Zhiqiang Shu | Berenberg |
Welcome to Kymera Therapeutics Quarterly Conference Call. Leading the call from management are Nello Mainolfi, Founder and CEO; Jared Gollob, Chief Medical Officer; and Bruce Jacobs, Chief Financial Officer. After management's prepared remarks, we will open the call to your questions. [Operator Instructions] Before we get started, I would like to remind everyone that some of the comments that management may make on this call include forward-looking statements, as outlined in the press release. Actual events and results could differ materially from those expressed or implied by any forward-looking statements as a result of various risks, uncertainties and other factors, including those set forth in Kymera's most recent filings with the SEC and any other future filings that the Company may make with the SEC.